Department of Cardiology, Zhengzhou University People's Hospital; Central China Fuwai Hospital; Central China Branch of the National Cardiovascular Center; Henan Provincial People's Hospital; Henan-China.
Xiangya School of Medicine, Central South University; Hunan-China.
Anatol J Cardiol. 2020 Jun;23(6):342-348. doi: 10.14744/AnatolJCardiol.2020.05043.
The purpose of this study was to determine the effects of surgical resection of muscle layer on the long-term survival of patients with hypertrophic obstructive cardiomyopathy (HOCM).
The original study cohort consisted of 552 patients with hypertrophic cardiomyopathy (HCM), including 380 patients with HOCM and 172 patients with nonobstructive HCM. All these patients had a definite diagnosis in our center from October 1, 2009, to December 31, 2012. They were divided into three groups, viz., HOCM with myectomy group (n=194), nonoperated HOCM group (n=186), and nonobstructive HCM group (n=172). Median follow-up duration was 57.57±13.71 months, and the primary end point was a combination of mortality from all causes.
In this survival study, we compared the prognoses of patients with HOCM after myectomy, patients with nonoperated HOCM, and patients with nonobstructive HCM. Among the three groups, the myectomy group showed a lower rate of reaching the all-cause mortality with statistically indistinguishable overall survival compared with patients with nonobstructive HCM (p=0.514). Among patients with left ventricular outflow tract (LVOT) obstruction, the overall survival in the myectomy group was noticeably better than that in the nonoperated HOCM group (log-rank p<0.001). Parameters that showed a significant univariate correlation with survival included age, previous atrial fibrillation (AF), NT-proBNP, Cr, myectomy, and LV ejection fraction. When these variables were entered in the multivariate model, the only independent predictors of survival were myotomy [hazard ratio (HR): 0.109; 95% CI: 0.013-0.877, p<0.037], age (HR: 1.047; 95% CI: 1.007-1.088, p=0.021), and previous AF (HR: 2.659; 95% CI: 1.022-6.919, p=0.021).
Patients with HOCM undergoing myectomy appeared to suffer from a lower risk of reaching the all-cause mortality and demonstrated statistically indistinguishable overall survival compared with patients with nonobstructive HCM. Multivariate analysis clearly demonstrated myectomy as a powerful, independent factor of survival, confirming that the differences in long-term survival recorded in this study may be due to surgical improvement in the LVOT gradient.
本研究旨在确定肥厚型梗阻性心肌病(HOCM)患者肌肉层切除术对长期生存率的影响。
原始研究队列包括 552 名肥厚型心肌病(HCM)患者,其中 380 名 HOCM 患者和 172 名非梗阻性 HCM 患者。所有这些患者均于 2009 年 10 月 1 日至 2012 年 12 月 31 日在我们中心明确诊断。他们分为三组,即肌切除术组(n=194)、未手术 HOCM 组(n=186)和非梗阻性 HCM 组(n=172)。中位随访时间为 57.57±13.71 个月,主要终点是所有原因导致的死亡率。
在这项生存研究中,我们比较了肌切除术、未手术 HOCM 和非梗阻性 HCM 患者的 HOCM 预后。在这三组中,肌切除术组的全因死亡率较低,总生存率与非梗阻性 HCM 患者无统计学差异(p=0.514)。在左心室流出道(LVOT)梗阻患者中,肌切除术组的总生存率明显优于未手术 HOCM 组(对数秩检验 p<0.001)。与生存有显著单因素相关性的参数包括年龄、既往心房颤动(AF)、NT-proBNP、Cr、肌切除术和左心室射血分数。当这些变量纳入多变量模型时,唯一的独立生存预测因子是肌切开术[风险比(HR):0.109;95%可信区间:0.013-0.877,p<0.037]、年龄(HR:1.047;95%可信区间:1.007-1.088,p=0.021)和既往 AF(HR:2.659;95%可信区间:1.022-6.919,p=0.021)。
与非梗阻性 HCM 患者相比,接受肌切除术的 HOCM 患者发生全因死亡的风险似乎较低,且总生存率无统计学差异。多变量分析清楚地表明,肌切除术是生存的有力独立因素,证实本研究中记录的长期生存率差异可能归因于 LVOT 梯度的手术改善。